{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:36:32Z","timestamp":1793025392539,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04876-4","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:45:08Z","timestamp":1766828708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intravenous delivery of mesenchymal stromal cells reverses M\u00fcller cell endoplasmic reticulum stress in diabetic retinopathy"],"prefix":"10.1186","volume":"17","author":[{"given":"Wei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u00e1n O.","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanbing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2843-0769","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-5481","authenticated-orcid":false,"given":"Timothy","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"4876_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"4876_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580\u201391.","journal-title":"Ophthalmology"},{"issue":"9735","key":"4876_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"issue":"9","key":"4876_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","volume":"39","author":"JL Leasher","year":"2016","unstructured":"Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016;39(9):1643\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"4876_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","volume":"5","author":"S Zoungas","year":"2017","unstructured":"Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"4876_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1755-3768.2010.02079.x","volume":"89","author":"A Salam","year":"2011","unstructured":"Salam A, Mathew R, Sivaprasad S. Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmol. 2011;89(5):405\u201311.","journal-title":"Acta Ophthalmol"},{"key":"4876_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/728325","volume":"2012","author":"G Tremolada","year":"2012","unstructured":"Tremolada G, Del Turco C, Lattanzio R, Maestroni S, Maestroni A, Bandello F, et al. The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment. Exp Diabetes Res. 2012;2012:728325.","journal-title":"Exp Diabetes Res"},{"issue":"5","key":"4876_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4239\/wjd.v5.i5.697","volume":"5","author":"NK Agrawal","year":"2014","unstructured":"Agrawal NK, Kant S. Targeting inflammation in diabetes: newer therapeutic options. World J Diabetes. 2014;5(5):697\u2013710.","journal-title":"World J Diabetes"},{"issue":"4","key":"4876_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/14653240903080367","volume":"11","author":"JA Kode","year":"2009","unstructured":"Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11(4):377\u201391.","journal-title":"Cytotherapy"},{"issue":"1","key":"4876_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","volume":"54","author":"A Arrigo","year":"2022","unstructured":"Arrigo A, Aragona E, Bandello F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy. Ann Med. 2022;54(1):1089\u2013111.","journal-title":"Ann Med"},{"issue":"1","key":"4876_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1167\/iovs.04-0860","volume":"46","author":"C Gerhardinger","year":"2005","unstructured":"Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. Expression of acute-phase response proteins in retinal M\u00fcller cells in diabetes. Invest Ophthalmol Vis Sci. 2005;46(1):349\u201357.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"4876_CR12","first-page":"1553","volume":"45","author":"LL Kusner","year":"2004","unstructured":"Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal M\u00fcller cells. Invest Ophthalmol Vis Sci. 2004;45(5):1553\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4876_CR13","first-page":"339","volume":"100","author":"DG Puro","year":"2002","unstructured":"Puro DG. Diabetes-induced dysfunction of retinal M\u00fcller cells. Trans Am Ophthalmol Soc. 2002;100:339\u201352.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"4876_CR14","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1167\/iovs.08-2082","volume":"50","author":"EC Yego","year":"2009","unstructured":"Yego EC, Vincent JA, Sarthy V, Busik JV, Mohr S. Differential regulation of high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in M\u00fcller cells by IL-1beta and IL-6. Invest Ophthalmol Vis Sci. 2009;50(4):1920\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4876_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105931","volume":"175","author":"AJ Chucair-Elliott","year":"2022","unstructured":"Chucair-Elliott AJ, Oca\u00f1as SR, Pham K, Van Der Veldt M, Cheyney A, Stanford D, et al. Translatomic response of retinal M\u00fcller glia to acute and chronic stress. Neurobiol Dis. 2022;175:105931.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"4876_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/glia.24514","volume":"72","author":"SI Palko","year":"2024","unstructured":"Palko SI, Benoit MR, Yao AY, Mohan R, Yan R. ER-stress response in retinal M\u00fcller glia occurs significantly earlier than amyloid pathology in the alzheimer\u2019s mouse brain and retina. Glia. 2024;72(6):1067\u201381.","journal-title":"Glia"},{"issue":"3","key":"4876_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00125-018-4776-y","volume":"62","author":"J Yang","year":"2019","unstructured":"Yang J, Chen C, McLaughlin T, Wang Y, Le YZ, Wang JJ, et al. Loss of X-box binding protein 1 in M\u00fcller cells augments retinal inflammation in a mouse model of diabetes. Diabetologia. 2019;62(3):531\u201343.","journal-title":"Diabetologia"},{"issue":"2","key":"4876_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archophthalmol.2007.65","volume":"126","author":"HY Zeng","year":"2008","unstructured":"Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 2008;126(2):227\u201332.","journal-title":"Arch Ophthalmol"},{"key":"4876_CR19","doi-asserted-by":"crossref","unstructured":"McLaughlin T, Siddiqi M, Wang JJ, Zhang SX. Loss of XBP1 leads to Early-Onset retinal neurodegeneration in a mouse model of type I diabetes. J Clin Med. 2019;8(6).","DOI":"10.3390\/jcm8060906"},{"issue":"15","key":"4876_CR20","doi-asserted-by":"publisher","first-page":"14844","DOI":"10.1074\/jbc.M312948200","volume":"279","author":"CN Roybal","year":"2004","unstructured":"Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 2004;279(15):14844\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"4876_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13287-018-1059-y","volume":"9","author":"SL Elshaer","year":"2018","unstructured":"Elshaer SL, Evans W, Pentecost M, Lenin R, Periasamy R, Jha KA, et al. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse. Stem Cell Res Ther. 2018;9(1):322.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4876_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13287-022-02963-4","volume":"13","author":"X Lu","year":"2022","unstructured":"Lu X, Lv C, Zhao Y, Wang Y, Li Y, Ji C, et al. TSG-6 released from adipose stem cells-derived small extracellular vesicle protects against spinal cord ischemia reperfusion injury by inhibiting endoplasmic reticulum stress. Stem Cell Res Ther. 2022;13(1):291.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4876_CR23","doi-asserted-by":"publisher","first-page":"E961","DOI":"10.1152\/ajpendo.00155.2020","volume":"319","author":"R Luo","year":"2020","unstructured":"Luo R, Li L, Liu X, Yuan Y, Zhu W, Li L, et al. Mesenchymal stem cells alleviate palmitic acid-induced endothelial-to-mesenchymal transition by suppressing endoplasmic reticulum stress. Am J Physiol Endocrinol Metab. 2020;319(6):E961\u201380.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"4876_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00765-3","volume":"6","author":"X Xiao","year":"2021","unstructured":"Xiao X, Xu M, Yu H, Wang L, Li X, Rak J, et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a\/Src. Signal Transduct Target Ther. 2021;6(1):354.","journal-title":"Signal Transduct Target Ther"},{"key":"4876_CR25","doi-asserted-by":"publisher","first-page":"120264","DOI":"10.1016\/j.biomaterials.2020.120264","volume":"257","author":"T Wang","year":"2020","unstructured":"Wang T, Jian Z, Baskys A, Yang J, Li J, Guo H, et al. MSC-derived exosomes protect against oxidative stress-induced skin injury via adaptive regulation of the NRF2 defense system. Biomaterials. 2020;257:120264.","journal-title":"Biomaterials"},{"issue":"1","key":"4876_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-024-03647-x","volume":"15","author":"J He","year":"2024","unstructured":"He J, Liu B, Du X, Wei Y, Kong D, Feng B, et al. Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy. Stem Cell Res Ther. 2024;15(1):66.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4876_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-024-03715-2","volume":"15","author":"B Liu","year":"2024","unstructured":"Liu B, Wei Y, He J, Feng B, Chen Y, Guo R, et al. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy. Stem Cell Res Ther. 2024;15(1):120.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"4876_CR28","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1167\/iovs.17-23293","volume":"59","author":"J Augustine","year":"2018","unstructured":"Augustine J, Pavlou S, O\u2019Hare M, Harkin K, Stitt A, Curtis T, et al. Characterization of a spontaneously immortalized murine M\u00fcller glial cell line QMMuC-1. Invest Ophthalmol Vis Sci. 2018;59(3):1666\u201374.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4876_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2337\/db20-0840","volume":"70","author":"JY Shih","year":"2021","unstructured":"Shih JY, Lin YW, Fisch S, Cheng JT, Kang NW, Hong CS, et al. Dapagliflozin suppresses ER stress and improves subclinical myocardial function in diabetes: from bedside to bench. Diabetes. 2021;70(1):262\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"4876_CR30","doi-asserted-by":"publisher","first-page":"18019","DOI":"10.1038\/s41598-017-18144-w","volume":"7","author":"AG Kay","year":"2017","unstructured":"Kay AG, Long G, Tyler G, Stefan A, Broadfoot SJ, Piccinini AM, et al. Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Sci Rep. 2017;7(1):18019.","journal-title":"Sci Rep"},{"issue":"3","key":"4876_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"10","key":"4876_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11892-021-01404-5","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y, Mitchell W, Elze T, Zebardast N. Association between diabetes, diabetic retinopathy, and glaucoma. Curr Diab Rep. 2021;21(10):38.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"4876_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2398200","volume":"56","author":"F Bohler","year":"2024","unstructured":"Bohler F, Bohler L, Taranikanti V. Targeting pericyte retention in diabetic retinopathy: a review. Ann Med. 2024;56(1):2398200.","journal-title":"Ann Med"},{"issue":"4","key":"4876_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.exer.2010.07.010","volume":"91","author":"S Kumar","year":"2010","unstructured":"Kumar S, Zhuo L. Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model. Exp Eye Res. 2010;91(4):530\u20136.","journal-title":"Exp Eye Res"},{"issue":"11","key":"4876_CR35","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1167\/iovs.04-1361","volume":"46","author":"RA Feit-Leichman","year":"2005","unstructured":"Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci. 2005;46(11):4281\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"4876_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-020-03267-w","volume":"382","author":"J Lv","year":"2020","unstructured":"Lv J, Bao S, Liu T, Wei L, Wang D, Ye W, et al. Sulforaphane delays diabetes-induced retinal photoreceptor cell degeneration. Cell Tissue Res. 2020;382(3):477\u201386.","journal-title":"Cell Tissue Res"},{"issue":"9","key":"4876_CR37","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1167\/iovs.04-0247","volume":"45","author":"PM Martin","year":"2004","unstructured":"Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45(9):3330\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4876_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2018.06.001","volume":"193","author":"Y Ichikawa","year":"2018","unstructured":"Ichikawa Y, Imamura Y, Ishida M. Inner nuclear layer thickness, a biomarker of metamorphopsia in epiretinal membrane, correlates with tangential retinal displacement. Am J Ophthalmol. 2018;193:20\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"4876_CR39","doi-asserted-by":"publisher","first-page":"14668","DOI":"10.1096\/fj.201901500R","volume":"33","author":"H Huang","year":"2019","unstructured":"Huang H, Kolibabka M, Eshwaran R, Chatterjee A, Schlotterer A, Willer H, et al. Intravitreal injection of mesenchymal stem cells evokes retinal vascular damage in rats. FASEB J. 2019;33(12):14668\u201379.","journal-title":"FASEB J"},{"issue":"10","key":"4876_CR40","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1002\/stem.2095","volume":"33","author":"A Tassoni","year":"2015","unstructured":"Tassoni A, Gutteridge A, Barber AC, Osborne A, Martin KR. Molecular mechanisms mediating retinal reactive gliosis following bone marrow mesenchymal stem cell transplantation. Stem Cells. 2015;33(10):3006\u201316.","journal-title":"Stem Cells"},{"issue":"6","key":"4876_CR41","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","volume":"46","author":"AJ Barber","year":"2005","unstructured":"Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46(6):2210\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4876_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/ceo.12084","volume":"41","author":"S McLenachan","year":"2013","unstructured":"McLenachan S, Chen X, McMenamin PG, Rakoczy EP. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina. Clin Exp Ophthalmol. 2013;41(6):582\u201392.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"4876_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-1059-y","volume":"9","author":"SL Elshaer","year":"2018","unstructured":"Elshaer SL, Evans W, Pentecost M, Lenin R, Periasamy R, Jha KA, et al. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2(Akita) mouse. Stem Cell Res Ther. 2018;9(1):322.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4876_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.18240\/ijo.2024.01.05","volume":"17","author":"T Wang","year":"2024","unstructured":"Wang T, Li HC, Ma J, Yu XL. Effect of sonic hedgehog gene-modified bone marrow mesenchymal stem cells on graft-induced retinal gliosis and retinal ganglion cells survival in diabetic mice. Int J Ophthalmol. 2024;17(1):34\u201341.","journal-title":"Int J Ophthalmol"},{"key":"4876_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160\u201380.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4876_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4876_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16(1):19\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4876_CR48","doi-asserted-by":"publisher","first-page":"6342594","DOI":"10.1155\/2022\/6342594","volume":"2022","author":"SH Abdel-Kawi","year":"2022","unstructured":"Abdel-Kawi SH, Hashem KS. Administration of melatonin in diabetic retinopathy is effective and improves the efficacy of mesenchymal stem cell treatment. Stem Cells Int. 2022;2022:6342594.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4876_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1136-x","volume":"10","author":"L Ling","year":"2019","unstructured":"Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, et al. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019;10(1):46.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"4876_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080784","volume":"8","author":"X Fu","year":"2019","unstructured":"Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784.","journal-title":"Cells"},{"issue":"2","key":"4876_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","volume":"143","author":"A Bronckaers","year":"2014","unstructured":"Bronckaers A, Hilkens P, Martens W, Gervois P, Ratajczak J, Struys T, et al. Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther. 2014;143(2):181\u201396.","journal-title":"Pharmacol Ther"},{"key":"4876_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117763","volume":"255","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhang W, Li Y, Ren L, Deng H, Yin X, et al. Cotransplantation of human umbilical cord mesenchymal stem cells and endothelial cells for angiogenesis and pulp regeneration in vivo. Life Sci. 2020;255:117763.","journal-title":"Life Sci"},{"key":"4876_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7806435","volume":"2018","author":"BY Peng","year":"2018","unstructured":"Peng BY, Dubey NK, Mishra VK, Tsai FC, Dubey R, Deng WP, et al. Addressing stem cell therapeutic approaches in pathobiology of diabetes and its complications. J Diabetes Res. 2018;2018:7806435.","journal-title":"J Diabetes Res"},{"issue":"6","key":"4876_CR54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jcyt.2024.02.020","volume":"26","author":"L Rong","year":"2024","unstructured":"Rong L, Wei W, Fang Y, Liu Y, Gao T, Wang L, et al. Clinical-grade human embryonic stem cell-derived mesenchymal stromal cells ameliorate diabetic retinopathy in db\/db mice. Cytotherapy. 2024;26(6):606\u201315.","journal-title":"Cytotherapy"},{"issue":"1","key":"4876_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12886-021-02171-3","volume":"22","author":"Q Liang","year":"2022","unstructured":"Liang Q, Li Q, Ren B, Yin ZQ. Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats. BMC Ophthalmol. 2022;22(1):67.","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"4876_CR56","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00417-010-1384-z","volume":"248","author":"Z Yang","year":"2010","unstructured":"Yang Z, Li K, Yan X, Dong F, Zhao C. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1415\u201322.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"4876_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109305","volume":"9","author":"B Mead","year":"2014","unstructured":"Mead B, Logan A, Berry M, Leadbeater W, Scheven BA. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS One. 2014;9(10):e109305.","journal-title":"PLoS One"},{"issue":"9","key":"4876_CR58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2174\/15665240113139990071","volume":"13","author":"Y Guan","year":"2013","unstructured":"Guan Y, Cui L, Qu Z, Lu L, Wang F, Wu Y, et al. Subretinal transplantation of rat MSCs and erythropoietin gene modified rat MSCs for protecting and rescuing degenerative retina in rats. Curr Mol Med. 2013;13(9):1419\u201331.","journal-title":"Curr Mol Med"},{"issue":"10","key":"4876_CR59","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.18240\/ijo.2021.10.06","volume":"14","author":"SN Chen","year":"2021","unstructured":"Chen SN, Xu ZG, Ma YX, Chen S, He GH, Han M, et al. Protective effect of LIF-huMSCs on the retina of diabetic model rats. Int J Ophthalmol. 2021;14(10):1508\u201317.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"4876_CR60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000492838","volume":"49","author":"X Gu","year":"2018","unstructured":"Gu X, Yu X, Zhao C, Duan P, Zhao T, Liu Y, et al. Efficacy and safety of autologous bone marrow mesenchymal stem cell transplantation in patients with diabetic retinopathy. Cell Physiol Biochem. 2018;49(1):40\u201352.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"4876_CR61","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.12.8.18","volume":"12","author":"H Kim","year":"2023","unstructured":"Kim H, Goh YS, Park SE, Hwang J, Kang N, Jung JS, et al. Preventive effects of exosome-rich conditioned medium from amniotic membrane-derived mesenchymal stem cells for diabetic retinopathy in rats. Transl Vis Sci Technol. 2023;12(8):18.","journal-title":"Transl Vis Sci Technol"},{"key":"4876_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13287-016-0299-y","volume":"7","author":"M Ezquer","year":"2016","unstructured":"Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther. 2016;7:42.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4876_CR63","first-page":"257","volume":"18","author":"JH Kong","year":"2015","unstructured":"Kong JH, Zheng D, Chen S, Duan HT, Wang YX, Dong M, et al. A comparative study on the transplantation of different concentrations of human umbilical mesenchymal cells into diabetic rats. Int J Ophthalmol. 2015;18(2):257\u201362.","journal-title":"Int J Ophthalmol"},{"key":"4876_CR64","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/OPTH.S21161","volume":"5","author":"SZ Scalinci","year":"2011","unstructured":"Scalinci SZ, Scorolli L, Corradetti G, Domanico D, Vingolo EM, Meduri A, et al. Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreous. Clin Ophthalmol. 2011;5:691\u20136.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"4876_CR65","doi-asserted-by":"publisher","first-page":"e84671","DOI":"10.1371\/journal.pone.0084671","volume":"9","author":"G Rajashekhar","year":"2014","unstructured":"Rajashekhar G, Ramadan A, Abburi C, Callaghan B, Traktuev DO, Evans-Molina C, et al. Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS One. 2014;9(1):e84671.","journal-title":"PLoS One"},{"issue":"5","key":"4876_CR66","doi-asserted-by":"publisher","first-page":"591","DOI":"10.7150\/ijms.38078","volume":"17","author":"C Yu","year":"2020","unstructured":"Yu C, Yang K, Meng X, Cao B, Wang F. Downregulation of long noncoding RNA MIAT in the retina of diabetic rats with Tail-vein injection of human Umbilical-cord mesenchymal stem cells. Int J Med Sci. 2020;17(5):591\u20138.","journal-title":"Int J Med Sci"},{"issue":"4","key":"4876_CR67","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.fcl.2006.06.014","volume":"11","author":"BJ Hoogwerf","year":"2006","unstructured":"Hoogwerf BJ, Sferra J, Donley BG. Donley, Diabetes mellitus\u2013overview. Foot Ankle Clin. 2006;11(4):703\u201315.","journal-title":"Foot Ankle Clin"},{"issue":"12","key":"4876_CR68","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1046\/j.1440-1681.1999.03172.x","volume":"26","author":"S Yuan","year":"1999","unstructured":"Yuan S, Liu Y, Zhu L. Vascular complications of diabetes mellitus. Clin Exp Pharmacol Physiol. 1999;26(12):977\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"4876_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tips.2021.11.011","volume":"43","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady A, Liu S, Klionsky DJ, Lip GYH, Tuomilehto J, Kavalakatt S, et al. Er stress in obesity pathogenesis and management. Trends Pharmacol Sci. 2022;43(2):97\u2013109.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"4876_CR70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","volume":"13","author":"C Hetz","year":"2017","unstructured":"Hetz C, Saxena S. Er stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13(8):477\u201391.","journal-title":"Nat Rev Neurol"},{"issue":"20","key":"4876_CR71","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1158\/0008-5472.CAN-21-1545","volume":"81","author":"JA Zundell","year":"2021","unstructured":"Zundell JA, Fukumoto T, Lin J, Fatkhudinov N, Nacarelli T, Kossenkov AV, et al. Targeting the IRE1\u03b1\/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers. Cancer Res. 2021;81(20):5325\u201335.","journal-title":"Cancer Res"},{"issue":"4","key":"4876_CR72","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/sj.onc.1209071","volume":"25","author":"K Zu","year":"2006","unstructured":"Zu K, Bihani T, Lin A, Park YM, Mori K, Ip C. Enhanced selenium effect on growth arrest by BiP\/GRP78 knockdown in p53-null human prostate cancer cells. Oncogene. 2006;25(4):546\u201354.","journal-title":"Oncogene"},{"key":"4876_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev.cellbio.21.122303.120200","volume":"22","author":"S Bernales","year":"2006","unstructured":"Bernales S, Papa FR. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol. 2006;22:487\u2013508.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4876_CR74","doi-asserted-by":"crossref","unstructured":"Song S, Hu T, Shi X, Jin Y, Liu S, Li X et al. ER stress-perturbed intracellular protein O-GlcNAcylation aggravates podocyte injury in diabetes nephropathy. Int J Mol Sci. 2023;24(24).","DOI":"10.3390\/ijms242417603"},{"key":"4876_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102289","volume":"52","author":"M Yuan","year":"2022","unstructured":"Yuan M, Gong M, He J, Xie B, Zhang Z, Meng L, et al. IP3R1\/GRP75\/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling. Redox Biol. 2022;52:102289.","journal-title":"Redox Biol"},{"issue":"9","key":"4876_CR76","first-page":"8336","volume":"16","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang J. Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice. Aging. 2023;16(9):8336\u201347.","journal-title":"Aging"},{"issue":"2","key":"4876_CR77","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2337\/db11-0315","volume":"61","author":"Y Zhong","year":"2012","unstructured":"Zhong Y, Li J, Chen Y, Wang JJ, Ratan R, Zhang SX. Activation of endoplasmic reticulum stress by hyperglycemia is essential for M\u00fcller cell-derived inflammatory cytokine production in diabetes. Diabetes. 2012;61(2):492\u2013504.","journal-title":"Diabetes"},{"issue":"10","key":"4876_CR78","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1681\/ASN.0000000000000189","volume":"34","author":"N Perico","year":"2023","unstructured":"Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, Casiraghi F, et al. Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM). J Am Soc Nephrol. 2023;34(10):1733\u201351.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4876_CR79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12967-024-06066-x","volume":"23","author":"T Yang","year":"2025","unstructured":"Yang T, Zhang N, Yang N. Single-cell sequencing in diabetic retinopathy: progress and prospects. J Transl Med. 2025;23(1):49.","journal-title":"J Transl Med"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04876-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04876-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04876-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:05Z","timestamp":1769608985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04876-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4876"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04876-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6169472\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were conducted in accordance with the National Institutes of Health guidelines for the care of animals. The animal studies came from the project of \"Effect and Mechanism of Mesenchymal Stem Cell in the Treatment of Diabetic Complications\u201dand was approved by the Laboratory Animal Ethical and Welfare Committee of Hebei Medical University (Approval No. IACUCHebmu-2021035, Date: 8 December 2021). UC-MSC cells were obtained from Qilu Cell Therapy Technology (Shandong, China) and the company obtained the cells with ethical approval and patient consent(Approval No. CXSL2300854).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TOB is global co-editor in chief of Stem Cell Research and Therapy. He will have no involvement in the peer review process or decisions on this article. He is also a Director and equity holder in Orbsen Therapeutics, a stem cell company. MD Griffin reports honoraria from the American Society of Nephrology; Th\u00e9a Pharma Ltd., Ireland; and Novo Nordisk; research funding from Orbsen Therapeutics Ltd.; and advisory roles as an Editorial Board member for the journals Transplantation and Frontiers in Pharmacology and an Associate Editor for Mayo Clinic Proceedings. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}